ArticleThe New England journal of medicine2017
Case 1-2017. A 70-Year-Old Woman with Gradually Progressive Loss of Language.
Abstract readCase ReportsClinical Conference
In one paragraph
Article in The New England journal of medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Prevalence of amyloid-β pathology in distinct variants of primary progressive aphasia.Annals of neurology · 2018Pooled it
- Primary Progressive Aphasia Treatment: Current Treatment Options in Neurology Article Topic: Management of Primary Progressive Aphasia.Current treatment options in neurology · 2025Review
- Article
- Neuroimaging in Frontotemporal Lobar Degeneration: Research and Clinical Utility.Advances in experimental medicine and biology · 2021Review
- Preferential Disruption of Auditory Word Representations in Primary Progressive Aphasia With the Neuropathology of FTLD-TDP Type A.Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology · 2019Article
- Flortaucipir tau PET imaging in semantic variant primary progressive aphasia.Journal of neurology, neurosurgery, and psychiatry · 2018Article
- Combined Pathologies in FTLD-TDP Types A and C.Journal of neuropathology and experimental neurology · 2018Article
- Molecular Imaging Biomarkers in Dementia: Amyloid and tau PET imaging aids evaluation of patients suspected of having Alzheimer disease or other dementias.Practical neurology (Fort Washington, Pa.)Article
- Development, Cross-Cultural Adaptation, and Psychometric Characteristics of the Persian Progressive Aphasia Language Scale in Patients With Primary Progressive Aphasia: A Pilot Study.Basic and clinical neuroscienceArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
M-Marsel MesulamFrom the Department of Neurology, Northwestern Medicine, Chicago (M.-M.M.); and the Departments of Neurology (B.C.D., J.C.S., K.A.J.), Psychiatry (J.C.S.), Speech, Language, and Swallowing Disorders and Reading Disabilities (D.H.), Radiology (R.G.G., K.A.J.), and Pathology (M.P.F.), Massachusetts General Hospital, and the Departments of Neurology (B.C.D.), Psychiatry (J.C.S.), Radiology (R.G.G., K.A.J.), and Pathology (M.P.F.), Harvard Medical School - both in Boston.
Bradford C DickersonFrom the Department of Neurology, Northwestern Medicine, Chicago (M.-M.M.); and the Departments of Neurology (B.C.D., J.C.S., K.A.J.), Psychiatry (J.C.S.), Speech, Language, and Swallowing Disorders and Reading Disabilities (D.H.), Radiology (R.G.G., K.A.J.), and Pathology (M.P.F.), Massachusetts General Hospital, and the Departments of Neurology (B.C.D.), Psychiatry (J.C.S.), Radiology (R.G.G., K.A.J.), and Pathology (M.P.F.), Harvard Medical School - both in Boston.
Janet C ShermanFrom the Department of Neurology, Northwestern Medicine, Chicago (M.-M.M.); and the Departments of Neurology (B.C.D., J.C.S., K.A.J.), Psychiatry (J.C.S.), Speech, Language, and Swallowing Disorders and Reading Disabilities (D.H.), Radiology (R.G.G., K.A.J.), and Pathology (M.P.F.), Massachusetts General Hospital, and the Departments of Neurology (B.C.D.), Psychiatry (J.C.S.), Radiology (R.G.G., K.A.J.), and Pathology (M.P.F.), Harvard Medical School - both in Boston.
Daisy HochbergFrom the Department of Neurology, Northwestern Medicine, Chicago (M.-M.M.); and the Departments of Neurology (B.C.D., J.C.S., K.A.J.), Psychiatry (J.C.S.), Speech, Language, and Swallowing Disorders and Reading Disabilities (D.H.), Radiology (R.G.G., K.A.J.), and Pathology (M.P.F.), Massachusetts General Hospital, and the Departments of Neurology (B.C.D.), Psychiatry (J.C.S.), Radiology (R.G.G., K.A.J.), and Pathology (M.P.F.), Harvard Medical School - both in Boston.
R Gilberto GonzalezFrom the Department of Neurology, Northwestern Medicine, Chicago (M.-M.M.); and the Departments of Neurology (B.C.D., J.C.S., K.A.J.), Psychiatry (J.C.S.), Speech, Language, and Swallowing Disorders and Reading Disabilities (D.H.), Radiology (R.G.G., K.A.J.), and Pathology (M.P.F.), Massachusetts General Hospital, and the Departments of Neurology (B.C.D.), Psychiatry (J.C.S.), Radiology (R.G.G., K.A.J.), and Pathology (M.P.F.), Harvard Medical School - both in Boston.
Keith A JohnsonFrom the Department of Neurology, Northwestern Medicine, Chicago (M.-M.M.); and the Departments of Neurology (B.C.D., J.C.S., K.A.J.), Psychiatry (J.C.S.), Speech, Language, and Swallowing Disorders and Reading Disabilities (D.H.), Radiology (R.G.G., K.A.J.), and Pathology (M.P.F.), Massachusetts General Hospital, and the Departments of Neurology (B.C.D.), Psychiatry (J.C.S.), Radiology (R.G.G., K.A.J.), and Pathology (M.P.F.), Harvard Medical School - both in Boston.
Matthew P FroschFrom the Department of Neurology, Northwestern Medicine, Chicago (M.-M.M.); and the Departments of Neurology (B.C.D., J.C.S., K.A.J.), Psychiatry (J.C.S.), Speech, Language, and Swallowing Disorders and Reading Disabilities (D.H.), Radiology (R.G.G., K.A.J.), and Pathology (M.P.F.), Massachusetts General Hospital, and the Departments of Neurology (B.C.D.), Psychiatry (J.C.S.), Radiology (R.G.G., K.A.J.), and Pathology (M.P.F.), Harvard Medical School - both in Boston.
Funding
THE ROLE OF ADVANCED CAA IN ALZHEIMER'S DEMENTIAP50AG005134 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI GOMEZ-ISLA, TERESA · 1985 to 2018
$42.1MNeuropathology CoreP30AG013854 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI VASSAR, ROBERT J · 1996 to 2020
$28.9MLanguage in Primary Progressive AphasiaR01DC008552 · NIDCD · NORTHWESTERN UNIVERSITY AT CHICAGO · PI MESULAM, MAREK-MARSEL M · 2007 to 2021
$8.5MNIA NIH HHS P30 AG013854NIA NIH HHS P50 AG005134NIDCD NIH HHS R01 DC008552
Abstract
PubMed holds no abstract for this paper.
Indexed as
AgedAphasia, Primary ProgressiveAutopsyBrainBrain ChemistryDNA-Binding ProteinsFemaleFrontotemporal Lobar DegenerationHumansPositron-Emission TomographyTemporal LobeDNA-Binding ProteinsTARDBP protein, human
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.